Key Notes on Chest Pain Types and Management
Imbalance in Myocardial Oxygen Supply and Demand
- Characterized by stable angina or acute coronary syndrome.
- Vascular smooth muscle spasms can impair cardiac blood flow, leading to ischemia and angina.
- Patients with Ischemic Heart Disease (IHD) and angina need EBG directed therapies, which include lifestyle changes and risk factor management.
Types of Chest Pain
Stable Angina
- Also known as Effort Induced Angina, Classic or Typical Angina.
- Symptoms typically include a short-acting, burning, heavy, or squeezing sensation.
- Some episodes can present with atypical symptoms such as fatigue, nausea, or sweating. Atypical presentations are common in women, diabetics, and older adults.
- Usually caused by fixed obstruction of a coronary artery due to plaque.
- Ischemia may be induced by activity but is relieved by rest or Nitroglycerin (NTG).
- The pattern of chest pain (CP) remains consistent over time, hence labeled as 'stable'.
Unstable Angina
- CP that increases in frequency and intensity with less effort.
- Episodes lasting longer than 20 minutes, new onset angina or increasing angina, or sudden shortness of breath (SOB) are red flags for unstable angina.
- Symptoms are not relieved by rest or NTG, indicating a form of acute coronary syndrome requiring hospitalization and aggressive treatment.
- Uncommon type of angina occurring at rest due to spasm of coronary arteries.
- Not linked to physical activity or stress.
- Responds well to coronary vasodilators such as NTG and Calcium Channel Blockers (CCBs).
Acute Coronary Syndrome
- Emergency situation, often due to plaque rupture leading to partial or complete thrombosis of a coronary artery.
- If untreated, can lead to myocardial necrosis (Myocardial Infarction - MI).
Drug Therapy for Chest Pain
- Four classes of drugs are commonly prescribed:
- Beta-Blockers (BBs)
- Calcium Channel Blockers (CCBs)
- Organic Nitrates
- Sodium Channel Blockers (Ranolazine)
Concomitant Diseases and Drug Commonality
- No Concurrent Conditions: Long-acting nitrate, Beta-Blockers.
- Recent Myocardial Infarction: Long-acting nitrate, Beta-Blockers.
- Asthma, COPD: Long-acting nitrate.
- Hypertension: Long-acting nitrate, Beta-Blockers.
- Diabetes: Long-acting nitrate.
- Chronic Renal Disease: Long-acting nitrate, Beta-Blockers, and Calcium Channel Blockers.
Beta Blockers
- Reduce myocardial oxygen demand by blocking beta-1 receptors, which decreases heart rate (HR), contractility, cardiac output (CO), and blood pressure (BP).
- Effective in increasing exercise duration and tolerance in patients with stable angina.
- First-line treatment for angina, but not for Prinzmetal angina as they can worsen symptoms.
- Should not be used in severe bradycardia and must be tapered off to prevent complications.
Calcium Channel Blockers
- Block the entrance of calcium into cardiac and vascular smooth muscle cells.
- Two types: Dihydropyridines (e.g., Amlodipine) affecting peripheral smooth muscles and non-dihydropyridines (e.g., Verapamil, Diltiazem) affecting the heart.
- Amlodipine: Minimal effects on cardiac function, useful for variant angina.
- Verapamil: Slows AV conduction, not advised for patients with AV conduction abnormalities.
- Diltiazem: Useful for Prinzmetal angina, but with caution in heart failure due to negative inotropic effects.
Nitrates
- Help relieve angina by relaxing vascular smooth muscle, reducing myocardial oxygen demand and increasing blood supply.
- Nitroglycerin (NTG) offers quick relief for angina.
- Caution with tolerance build-up; manage by implementing nitrate-free intervals.
Sodium Channel Blockers (Ranolazine)
- Helps manage angina by improving oxygen supply and demand.
- Can have QT interval prolongation and interactions with other drugs, requiring careful monitoring during therapy.
- Antianginal efficacy may be less pronounced in women, highlighting the need for personalized treatment strategies.